If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2001 2022

gemcitabine
Hyaluronoglucosaminidase
Multicenter Studies
Placebos
130-nm albumin-bound paclitaxel
Hepatocellular Carcinoma
Placebos
Safety
MDV 3100
Vaccinia
Thymidine Kinase
Viruses
Hepatocellular Carcinoma
Therapeutics
gemcitabine
Pancreatic Neoplasms
Neoplasms
ALT-803
130-nm albumin-bound paclitaxel

Research Output 1992 2018

8 Citations (Scopus)

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies

Hurwitz, H., Van Cutsem, E., Bendell, J., Hidalgo, M., Li, C. P., Salvo, M. G., Macarulla, T., Sahai, V., Sama, A., Greeno, E. W., Yu, K. H., Verslype, C., Dawkins, F., Walker, C., Clark, J. & O’Reilly, E. M., Aug 1 2018, In : Investigational New Drugs. 36, 4, p. 683-695 13 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Disease Progression
Survival
Confidence Intervals
Disease-Free Survival
17 Citations (Scopus)

Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)

Goldstein, D., Von Hoff, D. D., Moore, M., Greeno, E., Tortora, G., Ramanathan, R. K., Macarulla, T., Liu, H., Pilot, R., Ferrara, S. & Lu, B., Jan 1 2016, In : European Journal of Cancer. 52, p. 85-91 7 p.

Research output: Contribution to journalArticle

gemcitabine
Peripheral Nervous System Diseases
Pancreas
Adenocarcinoma
Survival
10 Citations (Scopus)

RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4

Kirby, M. K., Ramaker, R. C., Gertz, J., Davis, N. S., Johnston, B. E., Oliver, P. G., Sexton, K. C., Greeno, E. W., Christein, J. D., Heslin, M. J., Posey, J. A., Grizzle, W. E., Vickers, S. M., Buchsbaum, D. J., Cooper, S. J. & Myers, R. M., Oct 1 2016, In : Molecular Oncology. 10, 8, p. 1169-1182 14 p.

Research output: Contribution to journalArticle

RNA Sequence Analysis
Adenocarcinoma
gemcitabine
Survival
Neoplasms
11 Citations (Scopus)

Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors

Strosberg, J. R., Fisher, G. A., Benson, A. B., Anthony, L. B., Arslan, B., Gibbs, J. F., Greeno, E. W., Iyer, R. V., Kim, M. K., Maples, W. J., Philip, P. A., Wolin, E. M., Cherepanov, D. & Broder, M. S., Feb 28 2015, In : World Journal of Gastroenterology. 21, 8, p. 2450-2459 10 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Therapeutics
Somatostatin
Physicians
Interventional Radiology
8 Citations (Scopus)

Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: A Phase II pilot study

Jensen, E. H., Armstrong, L., Lee, C. K., Tuttle, T. M., Vickers, S. M., Sielaff, T. & Greeno, E. W., Jan 1 2014, In : HPB. 16, 2, p. 131-139 9 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Interferons
Chemoradiotherapy
Survival
Neoadjuvant Therapy